Overview
ADARx is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Our goal is to control the expression of specific disease drivers with highly selective siRNA targeted therapies, delivering life-changing treatments for patients with urgent unmet medical needs.
› Leadership › Board of Directors › Investors
